Polygenic risk score for atopic dermatitis in the Canadian population - 09/01/21
![](/templates/common/images/mail.png)
M.S. is supported by a Fonds de recherche du Québec - Santé (FRQS) Master’s Training Award. This study had support from the Quebec Respiratory Health Network (RHN; en/) pilot project grants and by the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy. The Canadian Institutes of Health Research (CIHR), and the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence provided core support for the CHILD study. C.L. is part of the Quebec RHN, the investigator of the CHILD study, the director of the Centre intersectoriel en santé durable de l’UQAC and the chairholder of the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergy (www.chairs.gc.ca). The GWAS data were made available by the European Commission as part of GABRIEL (A multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1 (Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control). This study makes use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available from www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 147 - N° 1
P. 406-409 - janvier 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?